# Correction: SENP3 inhibition suppresses hepatocellular carcinoma progression and improves the efficacy of anti-PD-1 immunotherapy

**Authors:** Peng Wang, Jiannan Qiu, Yuan Fang, Songmao Li, Kua Liu, Yin Cao, Guang Zhang, Zhongxia Wang, Xiaosong Gu, Junhua Wu, Chunping Jiang

PMC · DOI: 10.1038/s41418-025-01455-1 · 2025-02-06

## Full-text entities

- **Genes:** SENP3 (SUMO specific peptidase 3) [NCBI Gene 26168] {aka SMT3IP1, SSP3, Ulp1}, PDCD1 (programmed cell death 1) [NCBI Gene 5133] {aka ADMIO4, AIMTBS, CD279, PD-1, PD1, SLEB2}
- **Diseases:** hepatocellular carcinoma (MESH:D006528)

---
Source: https://tomesphere.com/paper/PMC12284259